Effects of tremorine, physostigmine and tremor blocking drugs on brain monoamines.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D002794:Choline / Q000494:pharmacology; D004336:Drug Antagonism; D005260:Female; D006426:Hemicholinium 3 / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D010830:Physostigmine / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*; D014202:Tremor / Q000209:etiology; D014203:Tremorine / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D000963:Antimetabolites; D006426:Hemicholinium 3; D012701:Serotonin; D001285:Atropine; D010830:Physostigmine; D002794:Choline; D014203:Tremorine; D009638:Norepinephrine